Today: 22 March 2026
Subscribe
Browse Category

Stock Market 31 December 2025

Qualcomm stock edges higher in thin year-end trade as Fed minutes land — what to watch next

Qualcomm stock edges higher in thin year-end trade as Fed minutes land — what to watch next

Qualcomm shares closed up 0.13% at $173.65 Tuesday, outperforming broader markets as the Dow, S&P 500, and Nasdaq all slipped. Trading was thin ahead of year-end, with investors parsing Federal Reserve minutes and watching moves in major tech stocks. Apple fell 0.3% and Nvidia dropped 0.4%. Qualcomm’s next earnings call is set for Feb. 4, 2026.
31 December 2025
···
Lumentum stock slips today as year-end trading thins out — what to watch next for LITE

Lumentum stock slips today as year-end trading thins out — what to watch next for LITE

Lumentum shares closed down 0.4% at $371.19 Tuesday, following a 4.65% drop the previous session. A regulatory filing showed director Thad Trent received 1,205 restricted stock units vesting over time. U.S. stocks finished slightly lower in thin, choppy trade, with technology shares under pressure. The next earnings report for Lumentum is scheduled for Feb. 5, 2026.
31 December 2025
·
Applied Digital stock slides after ChronoScale cloud spinout plan with Ekso; APLD traders eye Jan. 7 earnings

Applied Digital stock slides after ChronoScale cloud spinout plan with Ekso; APLD traders eye Jan. 7 earnings

Applied Digital shares fell 2.9% to $24.08 Tuesday after the company announced a non-binding term sheet to combine its cloud unit with Ekso Bionics and form a new company, ChronoScale. The stock traded between $24.03 and $26.33 on heavy volume. Applied Digital’s next earnings report is due Jan. 7.
31 December 2025
····
American Airlines stock rises into year-end after Chicago O’Hare expansion plan; AAL earnings window ahead

American Airlines stock rises into year-end after Chicago O’Hare expansion plan; AAL earnings window ahead

American Airlines shares closed up 1.25% at $15.33 Tuesday and were flat after hours. The carrier announced it will add 100 peak daily departures from Chicago O’Hare for spring break 2026 and extend seasonal flights to Paris and Dublin. Traders are watching costs from recent weather disruptions and the upcoming late-January earnings report.
31 December 2025
···
Texas Instruments stock today: TXN holds near $175 in late after-hours as Fed minutes, year-end flows mute chip trade

Texas Instruments stock today: TXN holds near $175 in late after-hours as Fed minutes, year-end flows mute chip trade

Texas Instruments closed at $175.42, down 0.15%, and held steady in late after-hours trading. Semiconductor ETFs, including SMH and SOXX, also slipped as traders weighed Fed policy signals and year-end positioning. Wall Street ended slightly lower, with tech shares dragging on the S&P 500 and Nasdaq. Texas Instruments remains about 21% below its 52-week high.
31 December 2025
···
PayPal stock slips after Fed minutes in thin year-end trade — what investors watch next

PayPal stock slips after Fed minutes in thin year-end trade — what investors watch next

PayPal shares slipped 0.7% to $59.10 in after-hours trading Tuesday following a subdued session for U.S. stocks. Federal Reserve minutes showed divisions over December’s rate cut, keeping attention on 2026 policy. Investors await PayPal’s next earnings report on Feb. 3 and Wednesday’s jobless claims data. Visa fell 0.3%, while Mastercard was little changed.
31 December 2025
··
Pfizer stock flat after hours as TD Cowen sticks with Hold; Feb. 3 results ahead

Pfizer stock flat after hours as TD Cowen sticks with Hold; Feb. 3 results ahead

Pfizer shares slipped 0.02% to $24.99 in late after-hours trading Tuesday. TD Cowen reiterated a Hold rating and $30 price target, citing weak longer-term trends. Investors await Pfizer’s next results for signs it can offset declining COVID sales and upcoming patent expirations. Pfizer forecasts 2026 revenue of $59.5–$62.5 billion and adjusted EPS of $2.80–$3.00.
31 December 2025
···
1 … 712 713 714 715 716 … 1,359

Stock Market Today

  • Apogee Therapeutics (APGE) Valuation Reflects Mixed Investor Sentiment Amid Share Price Decline
    March 22, 2026, 5:32 PM EDT. Apogee Therapeutics (APGE) shares dropped 4% last week and 15% over three months but delivered a 65.76% total shareholder return over one year. Trading at about 5 times book value, the valuation is below direct healthcare AI peers averaging 9.9 times but above the broader U.S. biotech industry average of 2.5 times. As a loss-making biotech with a net loss of US$255.8 million and a market cap near US$4.5 billion, the stock reflects investor optimism despite risks from early-stage clinical programs. The contrasting price-to-book multiples and mixed price momentum signal cautious investor sentiment as Apogee works on advancing its drug pipeline.
Go toTop